Impact of Bright Light Therapy on Prader-Willi Syndrome

Study acronym: PWS-LT
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Primary completion date changed from estimate of Jun 2026 to Sep 30, 2026
    • Study completion date: Dec 2026 to Dec 31, 2026
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised
    • Publications: details revised at 20 of 20 entries
    • Eligibility criteria expanded, about 5 words
  2. Re-verified, no change to tracked fieldsv6
  3. Enrollment target: 30 to 50
    • Primary completion date: Jan 2026 to Jun 2026
    • Study completion date: Jun 2026 to Dec 2026
    • Site contact updated
    v5
  4. Primary completion date: Dec 2024 to Jan 2026
    • Study completion date: Jun 2025 to Jun 2026
    v4
  5. Start date changed from estimate of Oct 2023 to Oct 1, 2023v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jul 2023 to Oct 2023
    • Site details revised
    v2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
Trial Details
NCT Number NCT05939453
Lead Sponsor Maimonides Medical Center
Collaborators: Foundation for Prader-Willi Research
Conditions
(from sponsor)		 Prader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia, Body Weight, Mood, Behavior
Related terms Behavior, Body Weight, Disorders of Excessive Somnolence, Hyperphagia, Prader-Willi Syndrome
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov